Application of SCRaMbLE system in screening longevity bacteria

Through the SCRaMbLE system, induced genomic rearrangement and screening in yeast, combined with flow cytometry and microfluidic control technology, the problem of low efficiency in screening long-lived strains in the existing technology is solved, efficient screening and lifespan detection is achieved, and the strains are significantly improved functionality and utilization.

CN119082257APending Publication Date: 2024-12-06SHENZHEN SECOND PEOPLES HOSPITAL (SHENZHEN INST OF TRANSLATIONAL MEDICINE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411370912.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-29
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing microbial screening methods are inefficient when screening longevity strains, making it difficult to quickly obtain the desired longevity strains, and the mutation and selection process are not controllable enough, making it difficult to accurately locate and screen specific beneficial traits.

Method used

The SCRaMbLE system is used to induce yeast strains to produce genomic rearrangement mutation libraries, and candidate strains are batch screened through flow cytometry, and lifespan detection is performed using microfluidic devices. Combined with the HSP104-eGFP reporter gene and loxPsym loci, achieving high efficiency within the genome-wide Edit and remodel.

Benefits of technology

Screening of long-lived strains through the SCRaMbLE system significantly improves the potential ability of the microbial genome, improves the utilization rate of functional strains, reduces production costs, and provides a new method to study replicative lifespan, and explores the development of biomarkers related to lifespan.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082257A_ABST
    Figure CN119082257A_ABST
Patent Text Reader

Abstract

The invention discloses an application of an SCRaMbLE system in screening of longevity bacteria. The combination effect of multiple genome rearrangement on yeast cell replicative life prolonging is reflected in longevity bacteria screened through an SCRaMbLE system, the potential ability of microbial genomes in senescence field research can be fully excavated, the utilization rate of functional strains is increased, and scientific research and production cost is reduced. The invention provides the application of the SCRaMbLE system in screening the longevity bacteria, variation generated by the SCRaMbLE system provides a new method for researching replicative life, and the method has great practical value for prolonging the life of microorganisms, exploring biomarkers related to the life and developing drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of molecular biology technology, and in particular to the application of the SCRaMbLE system in screening longevity bacteria. Background Art

[0002] With the continuous advancement of DNA editing and synthesis technologies, synthetic biology is revolutionizing the way we study and manipulate model organisms. The Synthetic Yeast Genome Project (Sc2.0) (www.syntheticyeast.org) is a pioneering effort to build the first synthetic genome for eukaryotic organisms, with the goal of developing a designer yeast genome with new properties. By adopting an iterative "design-build-test-learn" cycle strategy, the project has completed most of the chromosomes while gaining a lot of new scientific knowledge about the design of eukaryotic genomes, assembly methods, detection strategies, and the complex relationship between transcriptional regulation and three-dimensional genomes. A large number of design elements have been introduced into the Sc2.0 genome, which significantly enhances the versatility of yeast, allowing synthetic chromosomes to be used for rapid evolution and optimization of metabolic pathways. However, their potential applications in studying complex biological processes (such as aging) remain relatively unexplored. At the same time, as the goal of gradually integrating a single synthetic chromosome into a cell is gradually completed, there are many scenarios and opportunities for applications and exploration of new mechanisms in the future.

[0003] Aging is a physiological process driven by the accumulation of cellular damage. It is considered to be one of the key risk factors for many diseases of aging, including Alzheimer's disease, Parkinson's disease, tumor progression, and cardiovascular dysfunction. It is affected by a complex multi-factorial environment and the complexity of its underlying interaction network, which poses a major challenge to the study of aging. Saccharomyces cerevisiae (budding yeast) is a model organism commonly used for chemical and genetic manipulation due to the conservation of genes and pathways shared with humans. It is also widely used as a genetic model to explore the mechanisms of aging. However, although many aging-related genes and pathways have been identified in yeast through screening systems such as gene knockout or overexpression, it is particularly important to analyze the common effects of multiple genes on aging due to its complexity involving multiple levels.

[0004] The SCRaMbLE (Synthetic Chromosome Rearrangement and Modification by Loci Exchange) system embedded in the synthetic yeast genome has gradually become an important tool and is widely used in the optimization and pressure screening of microbial metabolites. By introducing a specific genome rearrangement mechanism, the SCRaMbLE system can achieve efficient genome-wide editing and modification in the microbial genome, thereby significantly improving the yield and production efficiency of the target metabolites. However, existing research has mostly focused on using the SCRaMbLE system to screen out high-yield metabolites or enhance the survival ability of microorganisms under specific pressures, but research on its application in microbial aging is still in a blank stage. However, traditional methods for microbial screening usually require a long screening cycle, are inefficient, and it is difficult to quickly obtain the desired long-lived strains. In addition, the mutation and selection processes are not controllable enough, making it difficult to accurately locate and screen out specific beneficial traits. Therefore, it is urgent to develop new uses of the SCRaMbLE system in screening long-lived strains, fully tap the potential capabilities of the genome, and improve the screening efficiency of strains. Summary of the invention

[0005] In view of the defects in the prior art, the present invention proposes the application of the SCRaMbLE system in screening longevity bacteria.

[0006] The present invention provides application of the SCRaMbLE system in screening longevity bacteria.

[0007] In some embodiments, the application is specifically: inducing yeast strains to produce a genome rearrangement mutation library, batch screening by flow cytometry to obtain candidate strains, and further performing lifespan detection on the candidate strains by a microfluidic device.

[0008] In some embodiments, the yeast strain is a Saccharomyces cerevisiae strain.

[0009] In some embodiments, the flow cytometric screening uses the HSP104-eGFP reporter gene.

[0010] In some embodiments, the Saccharomyces cerevisiae strain contains two loxPsym sites between the YMR011W gene and the YMR012W gene, and the URA3 marker gene is contained between the loxPsym sites.

[0011] In some embodiments, the Saccharomyces cerevisiae strain contains an artificial Saccharomyces cerevisiae chromosome synthesized according to the design principles of yeast genome synthesis.

[0012] In some embodiments, the long-lived bacteria have a higher replicative lifespan than the yeast strain.

[0013] In summary, compared with the prior art, the present invention achieves the following technical effects:

[0014] 1. The present invention provides an application of the SCRaMbLE system in screening longevity bacteria. The genome rearrangement generated by SCRaMbLE provides a new method for studying replicative lifespan, and has great practical value for extending the lifespan of microorganisms and exploring the development of biomarkers related to lifespan.

[0015] 2. The combined effect of multiple genome rearrangements on increasing the replicative lifespan of yeast cells was reflected in the screening of long-lived bacteria through the SCRaMbLE system. This can fully tap the potential capabilities of microbial genomes, improve the utilization rate of functional strains, and reduce production costs. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for use in the embodiments. It should be understood that the following drawings only illustrate certain embodiments of the present invention and should not be regarded as limiting the scope. For ordinary technicians in this field, other relevant drawings can be obtained based on these drawings without creative work.

[0017] Figure 1 The design, construction and characterization of synXIII involved in Example 1 of the present invention; wherein a is the design feature of synXIII construction, the dotted line indicates the range of the synthesis region after each replacement, and the arrow indicates the integration direction; the table on the right lists the differences between the chrXIII sequence features, the designed synXIII sequence features and the constructed synXIII sequence features; b is a schematic diagram of synXIII construction;

[0018] Figure 2 is the sum of the distribution of tRNA on chrXIII in the whole genome; a is the sum of chrXIII and other 15 chromosomes; b is the design of reintegration of tQ(CUG)M into YDL206W;

[0019] Figure 3 The construction and verification results of synXIII in the present invention; a is a schematic diagram of the hierarchical segmentation design; b is the sequencing analysis of the constructed synXIII whole genome, the sequencing depth represents its average value within a 500 bp window, and the PCR tags and loxPsym sites are identified by sequencing reads containing their synthetic specific sequences (sequencing reads ≥ 5);

[0020] Figure 4: Characterization of the synXIII strain of Example 2 of the present invention; a is a scanning electron microscope (SEM) image of BY4741 and synXIII strains, scale bar: 5.00 μm; b is a growth curve analysis of BY4741 and synXIII strains; c is the doubling time of the strain in YPD medium (n=3), the average doubling time of BY4741 is 1.0, and the data are expressed as the mean plus the error value; d is the cell viability response of the synXIII strain under normal and stress conditions; e is the survival curve of BY4741 and synXIII strains, the x-axis represents the number of daughter cells produced by the mother cell, each strain was measured with three replicates, and 40 cells were monitored each time; f is the differentially expressed genes of the synXIII strain identified at the transcriptome level and the proteome level compared with the BY4741 strain, and the genome-wide significance evaluation of the differentially expressed genes based on 6607 genes is P<7.56×10 -6 , and corresponds to log2(fold change) ≥1 or ≤-1; up-regulated and down-regulated genes are marked in red and green, respectively;

[0021] Figure 5 The life span measurement principle and results of the present invention; a is a schematic diagram of the microfluidic system for automatic life span measurement; b is a comparison of the average values ​​of HSP104-eGFP expression levels of BY4741, ted1Δ, fob1Δ, synXIII-O and synXIII-N; c is the correlation result between the mean expression level of HSP104-eGFP and life span in strains with different replicative life spans;

[0022] Figure 6 The results of screening and characterizing long-lived strains in the synXIII strain after SCRaMbLEd in Example 3 of the present invention; a is a schematic diagram of the SCRaMbLE and long-lived strain screening process, and HSP104 fused with eGFP (HSP104-eGFP) is used as a screening reporter gene for yeast replication lifespan. At the same time, the URA3 reporter gene was randomly integrated into the region between the two loxPsym sites, allowing positive screening of SCRaMbLE strains by 5-FOA, selecting SCRaMbLEants with lower fluorescence intensity by FACS, and then measuring lifespan using a microfluidic device; b is the lifespan extension rate (%) of 20 long-lived SCRaMbLEd strains compared with the parental synXIII strain Ycz063, n=3; c is the transcriptome analysis of the lifespan-extended strains compared with the synXIII strain Ycz063, the heat map represents the statistical significance of gene function (GO) enrichment of differentially expressed genes, and the numbers in brackets represent the Pearson correlation between statistical significance and lifespan extension, red, up-regulated; blue, down-regulated; green: relative lifespan compared with the initial synXIII strain;

[0023] Figure 7 The whole genome analysis results of 20 SCRaMbLEants with extended lifespans in Example 4 of the present invention; a is a schematic diagram of the structural changes of 20 long-lived SCRaMbLEants, the y-axis represents the relative aging extension of each SCRaMbLEant relative to the parental synXIII strain, represented by a color scale, and the red rectangle represents the aging regulatory factor site on the synXIII chromosome; b is the result of the variation of the lifespan change rate; the upward arrow in the figure represents an increase, the downward arrow represents a decrease, the blue represents a sequence inversion, the yellow represents a sequence duplication, and the disappeared sequence represents a deletion;

[0024] Figure 8 The results of the aging regulatory factor analysis of Example 4 of the present invention; a is the SCRaMbLE events on the chromosomes of synXIII of 20 strains, including deletions (DEL), inversions (INV) and duplications (DUP); b is an overview of SCRaMbLE genes and variant types; c is the variant representation of each gene in the set of 20 long-lived SCRaMbLEants (the number of times a variant is represented). The blue dots represent the selected genes (frequency ≥ 3) used for lifespan measurement in Figure D. The heat map shows the distribution of 5 different variant types for each selected gene. The colors represent the frequencies of different rearrangement event types of the target gene in these SCRaMbLE strains. CDS-CDS, CDS-NC, and CDS-UTR represent 3'-UTR genes replaced by CDS, non-coding (NC) sequences, or non-native UTRs, respectively;

[0025] Fig. 9 This is the result of the life span change rate when a specific gene is deleted in Example 4 of the present invention. DETAILED DESCRIPTION

[0026] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only embodiments of a part of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work should fall within the scope of protection of the present invention.

[0027] The yeast strains used in this application are BY4741 and BY4742;

[0028] The fragments were synthesized by Beijing Liuhe BGI (Hong Kong) Technology Co., Ltd.;

[0029] The culture media used in the present application include: YPD medium, SC (complete synthetic medium), synthetic medium without histidine (SC-His), synthetic medium without uracil (SC-Ura), and synthetic medium without leucine (SC-Leu).

[0030] The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials and reagents used are all commercially available unless otherwise specified.

[0031] Example 1 Design of synXIII

[0032] In this example, according to the principles of the yeast genome synthesis project (Sc2.0), the sequence of chromosome XIII (synXIII) of Saccharomyces cerevisiae was designed by BioStudio and named yeast_chr13_3_40, with a total length of 883,749 bp. The construction design process is as follows: Figure 1 Among them, 9% of the designed synXIII sequences were modified, including the deletion of 21 tRNAs, the insertion of 333 loxPsym sites (loxPysm sequences are 34 bp non-directional loxP sites that can be recombined in any direction), the replacement of TAG with TAA, and the introduction of 629 pairs of synthetic PCR tags, as shown in Table 1.

[0033] Table 1 Design of synXIII

[0034]

[0035] Among them, a refers to the wild-type telomere and its adjacent subtelomeric region being replaced by a universal telomere cap; b the transposable element region includes the functional characteristics of LTR retrotransposons, transposable element genes and long terminal repeat sequences; c the 9 introns located in the ribosomal subunit encoding gene are retained.

[0036] In order to improve the stability of the genome, according to the design principles of Sc2.0, the original nuclear tRNA genes were removed from the synthetic chromosomes based on the natural chromosomes. That is, all tRNA genes on synXIII will be concentrated in the tRNA Neochromosome. However, the tRNA gene tQ(CUG)M has only one copy in the entire genome and is essential ( Figure 2 a), so if Figure 2 As shown in b, before synthesizing synXIII, it was relocated to chrVI. The synXIII designed in the present application is 4.4% shorter than its native sequence.

[0037] Example 2 Construction and characterization of synXIII strain

[0038] (1) Construction of synXIII strain:

[0039] The synXIII strain was constructed using a hierarchical assembly strategy, such as Figure 3 As shown in a, the Gibson assembly strategy was used to assemble synthetic small fragments into synthetic fragments in vitro. The adjacent synthetic small fragments had a homologous sequence of 40 bases, and 6 to 7 synthetic fragments with a plasmid backbone could be integrated into a 10 to 15 kb DNA block at the same time. This "one-pot" in vitro assembly method can be used for both digestion of synthetic small fragments and promotion of assembly of synthetic small fragments, showing an efficiency comparable to that of digestion and purification of synthetic small fragments and then assembly. In vivo assembly used two wild-type strains (BY4741 and BY4742) to integrate from both ends at the same time. Using the standard SwAP-In method, the wild-type chromosome was replaced with 6 to 7 synthetic fragments as a synthetic large fragment in each round. The adjacent synthetic large fragments contained homologous sequences ranging from 500 to 800 bp, and the maximum synthetic large fragment used for replacement could be up to 70 kb. Therefore, the entire synXIII was effectively divided into 15 synthetic large fragments for replacement.

[0040] Specifically, the sequence of synXIII was divided into 15 synthetic large fragments (~70kb, named A~O), then divided into 84 synthetic fragments (~10kb), and finally divided into 421 synthetic small fragments (~3kb), which were synthesized by Beijing Liuhe BGI.

[0041] To verify whether the small fragment assembly results are successful, a single colony is selected for overnight culture at 37°C, and the connection between the small fragments is verified by PCR. The correct clone is further extracted for plasmid, verified by restriction endonuclease digestion, and finally verified by Sanger sequencing. A homologous region of 800 to 1000 bp is designed between each synthetic fragment for homologous recombination. When each round of synthetic large and small fragments is integrated, 5 to 6 synthetic fragments are mixed together with the same molar number and directly transformed and introduced into yeast to replace the corresponding wild-type sequence. Using the lithium acetate transformation method, candidate colonies are screened on selective nutrient-deficient culture medium plates, and the synthetic PCR tags and wild-type PCR tags are verified. When all wild-type PCR tags are converted to synthetic PCR tags, the next round of replacement and verification is carried out.

[0042] Synthetic synXIII strains were constructed by parallel integration in strains BY4741 and BY4742. The left-arm synthetic strain synXIIIA-I was formed by nine consecutive substitutions in BY4741 and the right-arm semisynthetic strain synXIIIJ-O (Ycz011 and Ycz017) was formed by six substitutions in BY4742. The two semisynthetic chromosomes were then homologously recombined into full-length synXIII using meiotic recombination-mediated assembly (MAR) and I-SceI-mediated strategies. Figure 1 As shown in b, 6 to 7 synthetic fragments were used to replace the wild chromosome XIII (dark gray) segment, and 9 and 6 stepwise replacements were performed in parallel from the left and right arms, respectively. The homologous regions (blue) generated by PCR using the connected fragments as templates through homologous recombination in yeast were designed to have a 500 bp overlap region with the two adjacent fragments to improve the replacement efficiency. I-SceI sites (yellow) were introduced on the two semi-synthetic chromosomes through I-SceI mediation and integration. I-SceI induction was performed after integration to generate double-strand breaks on the two semi-synthetic chromosomes. The 30 kb homology regions on the two semi-synthetic chromosomes were integrated into the complete synXIII (blue).

[0043] Karyotype analysis of the strain showed that chromosomes V and VIII of the strain were aberrant. The chromosome karyotype was then corrected by hybridization with synXIII-I to obtain synXIII strain Ycz020 ( Figure 3 b). The sequence of synXIII was finally confirmed by whole genome sequencing (WGS), revealing several “splicing” variants generated by homologous recombination (Table 2).

[0044] Table 2

[0045]

[0046]

[0047] (2) Characterization of synXIII strains:

[0048] The synXIII strain was characterized by scanning electron microscopy and analysis of its growth pattern.

[0049] Scanning electron microscopy procedure: The samples were incubated for 4 h at OD = 0.1, A600 = 0.6, and then fixed in 2.5% glutaraldehyde (Sigma, 340855, pH 7.4) for 2 h. Washed 3 times with 0.1 M phosphate buffer (pH 7.2), fixed in 1% osmium acid (Sigma, Cat. No.: 104239) for 2 h at 4 °C, dehydrated to 100% by a stepwise ascending ethanol series, and then dried using a critical point dryer (Quorum, K850). The samples were coated with an extremely thin gold film using a sputter coater (Cresstington, 108Auto) for 30 s and observed using an ultra-high resolution scanning electron microscope (Quasi-S, HITACHIRegulus 8100).

[0050] Colony size determination of synthetic and wild strains: A single colony of each strain was cultured overnight at 30°C in YPD liquid medium, and then about 300 colonies of each strain were spread on the corresponding agar plate and cultured at 30°C for about 3 days. Subsequently, the colonies on the plate were automatically identified, photographed, and analyzed using software such as Precision colony Picker (PIXL711712, Singer) that measures colony diameter in millimeters. The relative colony size of each strain was determined by dividing the colony size (diameter) of a single colony by the average colony size of BY4741.

[0051] Growth curve test: The strains cultured overnight were diluted with fresh medium to a starting density (OD) of 0.1, and 100 μL of the diluted cells were distributed into the wells of a Costar transparent polystyrene 96-well plate. Three biological replicates and 3 to 4 technical replicates were analyzed for each strain. The sealed 96-well plate was incubated at 30°C in the specified medium for 24 to 48 h using an Epoch2 microplate photometer (BioTek). The OD600 of each well was measured every 10 minutes. The doubling time (D) of each strain was calculated using GraphPad Prism 10 software.

[0052] The strain viability was determined under different culture conditions: 10-fold serial dilutions of synXIII and wild-type (BY4741 and BY4742) overnight cultures were used for plating. The conditions included: 30°C, YPD; 30°C, SC; 30°C, YPD + benzoyl; 30°C, YPD + hydrogen peroxide (1mM, pretreated for 2h); 30°C, YPD + methyl methane sulfone (MMS, 0.01% v / v); 30°C, YPD + camptothecin (0.1μg / mL); 30°C, YPD + rapamycin (0.2μg / mL); 30°C, YPD + cycloheximide (10μg / mL, pretreated for 2h); 30°C, YPD + sorbitol (1M); YPD, yeast extract peptone glucose medium; YPEG, yeast extract peptone glycerol ethanol medium; SC, fully synthetic medium.

[0053] To analyze the cellular functions of the synXIII strain and explore the potential impact of the synthetic chromosome on the transcriptome and proteome, the phenotype, growth pattern, transcriptome analysis, and proteome analysis of the synXIII strain and the wild-type strain were performed.

[0054] Subsequently, life span measurements were performed on wild-type and synXIII strains using a U-shaped high-pressure microfluidic chip assay to determine whether changes to the XIII chromosome sequence would affect replicative life span ( Figure 5 (a), lifespan measurement using HSP104 as an aging biomarker gene, each chip with 8 microchannels (left) is sealed on a thin glass slide (bottom). The geometry of the channels (red) and chambers (brown). Arrows indicate the direction of fluid flow, the larger mother cell is stuck in the chamber, and the daughter cells are washed away by the fluid. The number of divisions of the mother cell is recorded under a microscope, representing its replicative lifespan.

[0055] The specific measurement steps are as follows: All yeast strains tested were cultured in SC fully synthetic medium. Cells cultured overnight in 5 mL SC medium were diluted to an A600 of 0.1 in fresh medium and cultured at 30°C for 4 to 6 hours until A600 reached 0.6. The microfluidic device contains 8 microcolumns (side length ranges from 40 to 100 μm, chamber depth ranges from 3.8 to 4.2 μm), which can fix mother cells in the chamber. In contrast, newly formed daughter cells are washed away by the hydrodynamic flow of the surrounding liquid medium. One strain was tested per microcolumn and combined with time-lapse microscopy for high-resolution observation. The number of divisions of mother cells was monitored by continuous microscopy imaging for 60 hours to measure the number of daughter cells produced. For each strain, 40 mother cells were randomly selected, the number of daughter cells produced was counted, and the survival curve was plotted using Matlab.

[0056] The results are as follows Figure 4 As shown, Figure 4 In a, the synXIII strain and the wild-type strain are visually indistinguishable under scanning electron microscopy. Figure 4 Results from b to d showed that the synXIII strain exhibited a highly similar growth pattern to the wild-type BY4741 and BY4742 strains. Transcriptome analysis revealed 10 differentially expressed genes (DEGs) among 6606 genes, including 3 up-regulated genes and 7 down-regulated genes ( Figure 4 f). Proteomic analysis showed that there were 8 differentially expressed proteins in the synXIII strain compared with the native strain ( Figure 4 g). The above results indicate that synXIII has little effect on phenotypic fitness and cell physiology, and the replicative lifespan of the synXIII strain is comparable to that of the wild-type strain.

[0057] Example 3 Obtaining long-lived strains using the SCRaMbLE system of synXIII

[0058] Due to the integration of 333 loxPsym sites in synXIII, the induction of the SCRaMbLE system will generate a large mutant library from Sc2.0 yeast, thereby screening for potential long-lived strains. A screening system was constructed to quickly screen long-lived mutants from the population, and the enhanced green fluorescent protein gene (eGFP) was inserted before the stop codon of the HSP104 fusion with the LEU2 marker for selection. This method uses HSP104-eGFP as a reporter gene for strain lifespan. Specifically, long-lived strains show lower fluorescence compared to wild-type strains and can be identified by flow cytometry (FACS).

[0059] The FACS procedure is as follows:

[0060] Each SCRaMbLEant colony was cultured in 1 mL of SC medium in a 2.2 mL deep well plate for 24 hours. The next day, the cells were diluted into 1 mL of fresh medium with an A600 of 0.001 and grown to an A600 of 0.8, and each strain was tested by flow cytometry (BD, FACSAria cell sorter; Beckman, CytoFLEX). Flow cytometric analysis and cell sorting were performed at a rate of 10,000 events per second. The GFP protein was excited using a 488 nm laser, and the fluorescent signal was detected using a 528 / 29 filter. A preliminary scatter gating step was performed based on the forward scatter properties of the cells to collect single cell data. Flow cytometric analysis was performed by analyzing 100,000 cells from each sample.

[0061] To verify whether the HSP104-eGFP reporter gene is applicable to various yeast mutants, lifespan and HSP104-eGFP levels were measured in a series of well-studied mutants, including the well-known short-lived yeast (ted1Δ) and the long-lived yeast (fob1Δ) as an internal control ( Figure 5 a, b). The result is Figure 5 As shown in c, there is a negative correlation between lifespan and HSP104-eGFP levels, indicating that the HSP104-eGFP reporter system can be used to screen long-lived strains. In addition, an auxotrophic marker URA3 was integrated between two loxPsym sites between YMR011W and YMR012W on synXIII (270117-270525 bp) to ensure strong positive selection of the SCRaMbLEants library. By designing a SCRaMbLE-mediated screening workflow, strains with extended replicative lifespan were precisely located through inducible genome rearrangements ( Figure 6 a).

[0062] The steps for preparing the SCRaMbLEant library are as follows: pSCW11-Cre / EBD-HIS3 was introduced into the strain, and at the same time, a URA3 marker gene was integrated between the two loxPsym sites (270,117 to 270,525 bp) between YMR011W and YMR012W on synXIII to form the starting strain.

[0063] The starting strain was cultured in SC-His medium overnight, and the next day it was diluted into 5 mL of fresh SC-His medium with an A600 of 0.1. After 4 hours of culture, 1 μM estradiol inducer was added, shaken on a shaker at 200 rpm, and induced at 30 ° C for 8 hours. Finally, 200 μL of the solution was collected, the cells were washed with sterile water, and cultured on SC+5-FOA plates for 3 days. For each plate, 96 FOA-resistant single colonies were isolated from the plate, inoculated in a 96-deep-well plate, and cultured overnight with SC liquid medium. The next day, the strain was diluted into fresh medium to a cell density of 0.1, cultured to the logarithmic phase, and used for GFP fluorescence measurement. In this way, a library of approximately 6,000 SCRaMbLEant colonies was screened to finally select a total of 28 SCRaMbLEants with lower fluorescence, and further tested for lifespan through a microfluidic chip, and finally 20 long-lived strains were identified. Compared with the parental synXIII strain, these mutant strains showed different lifespan extension rates, ranging from 20.3% to 42.5% ( Figure 6 b). This application uses synXIII to screen for long-lived bacterial characteristics, providing a research basis for establishing a promising and easily accessible platform for efficient screening of long-lived strains.

[0064] Subsequently, a comprehensive in-depth transcriptomics analysis of the mechanisms of lifespan extension in the 20 synXIII strains was performed. This analysis revealed a clear correlation between long-lived strains and transcriptional patterns. Specifically, significant upregulation was observed in genes encoding ribosomal cellular components (gene ontology, GO:0005840), rRNA processing (GO:0006364), and nucleolus (GO:0005730). In addition, the expression levels of genes involved in cytoplasmic translation were also increased (GO:0002181)( Figure 6 c). In addition, the significance levels of these cellular processes correlated well with lifespan extension. Taken together, the data suggest that protein synthesis capacity is increased in long-lived yeast strains, indicating a strong association between the activity of the protein synthesis machinery and lifespan extension.

[0065] Example 4: Interpretation of the combined effects of aging regulators and lifespan extension based on multiple structural variations

[0066] Whole genome sequencing (WGS) analysis was performed to decode genomic rearrangement events that may contribute to the longevity phenotype ( Figure 7 a). A total of 114 recombination events, including deletions, inversions, and duplications, were observed in 20 long-lived strains, with frequencies of 57.9% (66), 36.0% (41), and 6.1% ( Figure 8 a) Among them, all identified SCRaMbLE events covered 111 genes at different frequencies, accounting for approximately 22.5% of all genes on synXIII.

[0067] Different types of structural variations have been observed, including deletions, duplications, and inversions. In inversion events, the coding domain sequence can be linked to a convergent CDS, non-cognate UTR, or other non-coding sequences, resulting in three subtypes, namely CDS-CDS, CDS-non-cognate UTR, and CDS-NC ( Figure 8 ). That is, the present application observed 93, 35 and 119 genes deleted, duplicated or 3'-UTR altered mutations in 20 strains with extended lifespan, respectively ( Figure 8 b, c).

[0068] Previous studies using yeast deletion panels have found that some gene deletions can lead to extended lifespan, and found that many of these genes were removed in long-lived strains after SCRaMbLE. Some of these deleted genes were verified to lead to extended lifespan, with a variation rate of 19.1% to 30.9% ( Fig. 9 ). Overall, these results demonstrate that the SCRaMbLE system allows the generation of abundant genomic rearrangements in synthetic yeast that can be associated with replicative lifespan phenotypes.

[0069] To gain insight into the causal links between genotypic and phenotypic changes, we reconstructed some of the key structural variants observed in the lifespan-extended SCRaMbLE post-synXIII strains. Among these, strain Ycz315 stood out for its significantly extended lifespan and contained a range of genomic changes. Specifically, compared to the parental strain, the genome of Ycz315 included 1 deletion, DEL1 (47629bp to 50039bp), and 3 inversions, INV1 (337292bp to 346702bp), INV2 (176041bp to 184342bp), and INV3 (353392bp to 346673bp). In addition, a large duplication, DUP1 (75003bp to 88593bp), was found in Ycz315. To verify the effect of each variant on lifespan, each structural variant was reconstructed individually in synXIII and the replicative lifespan of the resulting strain was measured (strain Ycz020).

[0070] The results are as follows Figure 7 As shown in b, INV1 had little effect on lifespan extension, while INV2 (5.9%) and DEL1 (8.6%) had a slight effect on lifespan extension. Reconstruction of some structural variants can produce significant effects. Specifically, DUP1 showed up to 11.1% lifespan extension, while INV3 showed up to 17.8% lifespan extension. In summary, the findings of this application not only demonstrate the potential of synthetic chromosomes to identify new genomic targets in aging research, but also demonstrate the combined effects of multiple genomic rearrangements on the increase in replicative lifespan of yeast cells, as shown in the Ycz315 strain.

[0071] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. Application of SCRaMbLE system in screening long-lived bacteria.

2. The use according to claim 1, characterized in that: The application is specifically as follows: inducing yeast strains to produce a gene rearrangement mutation library, batch screening by flow cytometry to obtain candidate strains, and further performing life span detection on the candidate strains by a microfluidic device.

3. The use according to claim 2, characterized in that: The flow cytometric screening used the HSP104-eGFP reporter gene.

4. The use according to claim 2, characterized in that: The yeast strain is a Saccharomyces cerevisiae strain.

5. The use according to claim 4, characterized in that: The yeast strain contains two loxPsym sites between the YMR011W gene and the YMR012W gene, and the loxPsym sites contain the URA3 marker gene.

6. The use according to claim 4, characterized in that: The cerevisiae yeast strain contains an artificial cerevisiae yeast chromosome designed according to the yeast genome synthesis principle.

7. The use according to claim 1, characterized in that: The replication lifespan of the long-lived bacteria is higher than that of the yeast strain described in claim 2.